Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
暂无分享，去创建一个
S. Tu | Lung-Ji Chang | Jilong Yang | Xuan Zhou | Yanjie He | Chunyan Yue | Zhao Liang | L. Deng | Chao-Yang Song | Rui Huang | Yuchen Liu | Jingwen Du | Meifang Li | Yuhua Li | Zhenling Guo | Chunsheng Wang | Anqin Wu | Weijun Zhou | Yongqian Li | Cheng Jiao | R. Huang